CatalystWireBeta

Oxford Instruments

OXIG · Main Market · Industrial Goods and Services · mcap £1,620m · 2966.0p

Beta Briefing, track record and signals & risks are not ready for Oxford Instruments yet.

We follow 967 UK small caps and every one of their announcements – often hundreds per company. 71 companies are already wired into a briefing: browse them.

All announcements Monitoring checked today, 14:35

DateTypeAnnouncementDay
13 Oct 26 Trading update Interim Trading Update
H1 order intake up 44% with revenue growth of 8% and margin expansion; confidence in full-year guidance
09 Oct 26 Routine Transaction in Own Shares
02 Oct 26 Routine Transaction in Own Shares
01 Oct 26 Routine Total Voting Rights
01 Oct 26 Routine Issue of Equity
25 Sep 26 Routine Transaction in Own Shares
18 Sep 26 Routine Transaction in Own Shares
14 Sep 26 Director dealing Director/PDMR Shareholding
11 Sep 26 Routine Transaction in Own Shares
04 Sep 26 Routine Transaction in Own Shares
01 Sep 26 Routine Total Voting Rights
01 Sep 26 Routine Issue of Equity
28 Aug 26 Routine Transaction in Own Shares
21 Aug 26 Routine Transaction in Own Shares
14 Aug 26 Routine Transaction in Own Shares
07 Aug 26 Routine Transaction in Own Shares
05 Aug 26 Director dealing Director/PDMR Shareholding
03 Aug 26 Director dealing Director/PDMR Shareholding
03 Aug 26 Routine Issue of Equity
03 Aug 26 Routine Total Voting Rights
31 Jul 26 Routine Transaction in Own Shares
29 Jul 26 Routine Block Listing Application and Issue of Equity
28 Jul 26 Director dealing Director/PDMR Shareholding
24 Jul 26 Routine Transaction in Own Shares
23 Jul 26 Routine Result of AGM
20 Jul 26 Holding Holding(s) in Company
17 Jul 26 Routine Transaction in Own Shares
15 Jul 26 Holding Holding(s) in Company
10 Jul 26 Routine Transaction in Own Shares
03 Jul 26 Routine Transaction in Own Shares
01 Jul 26 Routine Total Voting Rights
01 Jul 26 Routine Issue of Equity
26 Jun 26 Routine Transaction in Own Shares
23 Jun 26 Routine Publication of Annual Report 2026 and Notice of Annual General Meeting 2026
19 Jun 26 Routine Transaction in Own Shares
12 Jun 26 Routine Transaction in Own Shares
09 Jun 26 Results Final Results
Full-year revenue down 4.6% to £423.2m, but adjusted operating profit up 30bps on constant currency; Advanced Technologies order intake up 28%.
−9.3%
01 Jun 26 Routine Total Voting Rights
01 Jun 26 Routine Issue of Equity
27 May 26 Holding Holding(s) in Company
22 May 26 Routine Transaction in Own Shares
14 May 26 Routine Issue of Equity
08 May 26 Routine Transaction in Own Shares
01 May 26 Routine Total Voting Rights
01 May 26 Routine Transaction in Own Shares
24 Apr 26 Routine Transaction in Own Shares
17 Apr 26 Routine Transaction in Own Shares
14 Apr 26 Holding Holding(s) in Company
14 Apr 26 Trading update Trading Update
Full-year performance in line with expectations; Advanced Technologies order intake up 30%, book-to-bill 1.07.
+5.4%
13 Apr 26 Holding Holding(s) in Company
13 Apr 26 Holding Holding(s) in Company
10 Apr 26 Routine Transaction in Own Shares
07 Apr 26 Routine Transaction in Own Shares
01 Apr 26 Holding Holding(s) in Company
01 Apr 26 Routine Total Voting Rights
30 Mar 26 Holding Holding(s) in Company
27 Mar 26 Routine Transaction in Own Shares
25 Mar 26 Holding Holding(s) in Company
20 Mar 26 Routine Transaction in Own Shares
20 Mar 26 Holding Holding(s) in Company
17 Mar 26 Holding Holding(s) in Company
13 Mar 26 Routine Transaction in Own Shares
05 Mar 26 Holding Holding(s) in Company
05 Mar 26 Routine Transaction in Own Shares
04 Mar 26 Routine Transaction in Own Shares
03 Mar 26 Routine Transaction in Own Shares
02 Mar 26 Routine Total Voting Rights
02 Mar 26 Extension of Share Buyback Programme
Oxford Instruments extends share buyback programme by £50 million to March 2027.
+0.2%
27 Feb 26 Routine Transaction in Own Shares
26 Feb 26 Routine Transaction in Own Shares
25 Feb 26 Routine Transaction in Own Shares
24 Feb 26 Routine Transaction in Own Shares
23 Feb 26 Routine Transaction in Own Shares
20 Feb 26 Routine Transaction in Own Shares
19 Feb 26 Routine Transaction in Own Shares
18 Feb 26 Routine Transaction in Own Shares
17 Feb 26 Routine Transaction in Own Shares
16 Feb 26 Routine Transaction in Own Shares
13 Feb 26 Routine Transaction in Own Shares
12 Feb 26 Routine Transaction in Own Shares
10 Feb 26 Routine Transaction in Own Shares
09 Feb 26 Routine Transaction in Own Shares
06 Feb 26 Routine Transaction in Own Shares
05 Feb 26 Routine Transaction in Own Shares
04 Feb 26 Routine Transaction in Own Shares
03 Feb 26 Routine Transaction in Own Shares
02 Feb 26 Routine Total Voting Rights
02 Feb 26 Routine Transaction in Own Shares
30 Jan 26 Routine Transaction in Own Shares
29 Jan 26 Routine Transaction in Own Shares
28 Jan 26 Routine Transaction in Own Shares
27 Jan 26 Routine Transaction in Own Shares
26 Jan 26 Routine Transaction in Own Shares
23 Jan 26 Holding Holding(s) in Company
22 Jan 26 Routine Transaction in Own Shares
21 Jan 26 Routine Transaction in Own Shares
20 Jan 26 Routine Transaction in Own Shares
19 Jan 26 Holding Holding(s) in Company
15 Jan 26 Routine Transaction in Own Shares
15 Jan 26 Trading update Trading Update
Oxford Instruments reconfirms full-year outlook; Advanced Technologies orders up 44.5%, NanoScience sold for £48.5m net cash.
+5.4%
14 Jan 26 Holding Holding(s) in Company
13 Jan 26 Holding Holding(s) in Company
13 Jan 26 Routine Transaction in Own Shares
12 Jan 26 Routine Transaction in Own Shares
09 Jan 26 Routine Transaction in Own Shares
08 Jan 26 Routine Transaction in Own Shares
07 Jan 26 Routine Transaction in Own Shares
06 Jan 26 Routine Transaction in Own Shares
02 Jan 26 Routine Block listing Interim Review
02 Jan 26 Routine Total Voting Rights
23 Dec 25 Director dealing Director/PDMR Shareholding
22 Dec 25 Routine Transaction in Own Shares
19 Dec 25 Routine Transaction in Own Shares
18 Dec 25 Routine Transaction in Own Shares
17 Dec 25 Holding Holding(s) in Company
17 Dec 25 Routine Transaction in Own Shares
16 Dec 25 Routine Transaction in Own Shares
15 Dec 25 Routine Transaction in Own Shares
12 Dec 25 Routine Transaction in Own Shares
11 Dec 25 Routine Transaction in Own Shares
10 Dec 25 Routine Transaction in Own Shares
09 Dec 25 Routine Transaction in Own Shares
08 Dec 25 Holding Holding(s) in Company
03 Dec 25 Routine Transaction in Own Shares
02 Dec 25 Routine Transaction in Own Shares
01 Dec 25 Routine Total Voting Rights
01 Dec 25 Routine Transaction in Own Shares
28 Nov 25 Routine Transaction in Own Shares
27 Nov 25 Routine Transaction in Own Shares
26 Nov 25 Routine Transaction in Own Shares
25 Nov 25 Routine Transaction in Own Shares
24 Nov 25 Routine Transaction in Own Shares
21 Nov 25 Routine Transaction in Own Shares
20 Nov 25 Routine Transaction in Own Shares
19 Nov 25 Routine Transaction in Own Shares
18 Nov 25 Routine Transaction in Own Shares
17 Nov 25 Routine Transaction in Own Shares
12 Nov 25 Holding Holding(s) in Company
11 Nov 25 Routine Transaction in Own Shares
11 Nov 25 Results Half-year Results
H1 revenue down 7.9% and operating profit down 22.9% due to Q1 disruption; Q2 recovery and full-year guidance unchanged.
+15.0%
10 Nov 25 Routine Transaction in Own Shares
07 Nov 25 Routine Transaction in Own Shares
06 Nov 25 Routine Transaction in Own Shares
05 Nov 25 Routine Transaction in Own Shares
04 Nov 25 Routine Transaction in Own Shares
03 Nov 25 Routine Total Voting Rights
03 Nov 25 Routine Transaction in Own Shares
31 Oct 25 Routine Transaction in Own Shares
30 Oct 25 Routine Transaction in Own Shares
29 Oct 25 Routine Transaction in Own Shares
28 Oct 25 Routine Transaction in Own Shares
27 Oct 25 Routine Transaction in Own Shares
24 Oct 25 Routine Transaction in Own Shares
23 Oct 25 Routine Transaction in Own Shares
22 Oct 25 Routine Transaction in Own Shares
21 Oct 25 Routine Transaction in Own Shares
20 Oct 25 Change of Auditor
Oxford Instruments plc (the "Company"), a leading provider of high technology products and systems for industry and research, announces that, following a formal tender process, it has appointed Deloitte LLP ("Deloitte")
+1.2%
20 Oct 25 Routine Transaction in Own Shares
17 Oct 25 Routine Transaction in Own Shares
16 Oct 25 Routine Transaction in Own Shares
15 Oct 25 Routine Transaction in Own Shares
14 Oct 25 Routine Transaction in Own Shares
13 Oct 25 Trading update Half Year Trading Update - Correction
H1 revenues down 8% on tariff disruption; expecting stable full year on organic constant currency basis.
−7.6%
13 Oct 25 Routine Transaction in Own Shares
13 Oct 25 Trading update Half Year Trading Update
H1 revenue down 8% on tariff disruption; expecting stable full year as Q2 momentum continues and H2 margins improve.
−7.6%
10 Oct 25 Routine Transaction in Own Shares
09 Oct 25 Routine Transaction in Own Shares
08 Oct 25 Routine Transaction in Own Shares
07 Oct 25 Routine Transaction in Own Shares

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note